News you can use: health & drug safety updates

2015

  • October 1, 2015
    Along with other celiac disease organizations, the National Foundation for Celiac Awareness (NFCA) has long called for gluten to be called out on medication labels or, preferably, completely removed from medications. In 2013, Ohio Democratic State Representative Tim Ryan introduced the 2013 Gluten in Medicine Disclosure Act, which would mandate that gluten be disclosed as an ingredient on all medication labels. Congressman Ryan has reintroduced the bill in the 114th Congress as the Gluten in Medicine Disclosure Act of 2015. The legislation contains the same
  • October 1, 2015

    APhA Pharmacy Today

  • September 30, 2015
    A Conversation with Douglas Throckmorton, M.D., Deputy Director for Regulatory Programs, Center for Drug Evaluation and Research, FDA - Last year Americans filled 4.3 billion prescriptions. It is clear that prescription drugs play an important role in managing a range of medical conditions and are widely used in homes across the United States.. But the drug life-cycle is not complete until the medicine has been consumed in its entirety or eventually discarded properly. However, little attention is given to the potential risks, such as accidental exposure or
  • September 29, 2015
    The AMA Task Force believes that physicians have a professional obligation to reverse the nation’s opioid epidemic. The five goals of the task force are: 1. Increase physicians’ registration and use of effective Prescription Drug Monitoring Programs (PDMPs) 2. Enhance physicians’ education on effective, evidence-based prescribing 3. Reduce the stigma of pain and promote comprehensive assessment and treatment 4. Reduce the stigma of substance use disorder and enhance access to treatment 5. Expand access to naloxone in the community and through co-prescribing
  • September 25, 2015
    The Consumer Healthcare Products Association (CHPA) Educational Foundation released a national survey, which was conducted to identify consumers’ knowledge gaps around the appropriate use, storage, and disposal of oral over-the-counter (OTC) medicines and to inform future foundation programs and initiatives. The survey was conducted online by Harris Poll in February 2015 among 2,002 U.S. adults 18 and older who have used or purchased oral OTC medicines in the last six months. While the majority of consumers are using OTC medicines safely and appropriately, three in five consumers (62
  • September 24, 2015
    A bill passed by the California Legislature would require the state’s pharmacies to provide translations of prescription drug labels and medication instructions into any of five specified languages. If signed into law by Governor Jerry Brown, the bill, AB 1073, would take effect January 1, 2016, and would require translated directions “printed on the prescription container, label, or on a supplemental document” in Spanish, Tagalog, Chinese, Vietnamese, or Korean, to be provided upon the request of the patient. If the bill becomes law, dispensers
  • September 24, 2015
    The National Institute on Alcoholism and Alcohol Abuse has introduced a new tool to help colleges cut down on student drinking, CNN reports. CollegeAIM includes 60 alcohol interventions, with information on their effectiveness, costs and barriers to implementation. The guide includes a wide variety of interventions, from requiring Friday morning classes to restricting happy hours and other drinking promotions. CollegeAIM can help schools choose wisely among available strategies, boosting their chances for success and helping them improve the health and safety of their students.
  • September 21, 2015
    The number of mobile health applications available to consumers now surpasses 165,000, as developers incorporate innovative data collection features linked to sensors and wearables, according to a new report released today by the IMS Institute for Healthcare Informatics. While most available apps focus on overall wellness, healthcare systems and professionals are expressing greater interest and excitement in broader app use as barriers to mainstream adoption of mHealth are removed—especially in the area of chronic disease management.
  • September 16, 2015
    Otsuka Pharmaceutical and Proteus Digital Health announced that the FDA has accepted their New Drug Application (NDA) for the drug Abilify, which will be manufactured with an embedded, ingestible sensor that tracks treatment adherence and physiologic response. Both the sensor and Abilify have already received separate FDA approvals, but this marks the first time the FDA will evaluate a sensor-embedded, clinically approved drug. Proteus’ sensor is a silicon chip, approximately the size of a grain of sand, that uses digestive juices to generate a
  • September 11, 2015
    The Food and Drug Administration (FDA) has strengthened the warning for the type 2 diabetes medicine canagliflozin (Invokana, Invokamet) related to the increased risk of bone fractures and added new information about decreased bone mineral density. Bone mineral density relates to the strength of a person’s bones. To address these safety concerns, FDA added a new Warning and Precaution and revised the Adverse Reactions section of the Invokana and Invokamet drug labels. Health care professionals should consider factors that contribute to fracture

Pages